{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:11:12Z","timestamp":1648707072999},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11789-015-0069-x","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T06:57:44Z","timestamp":1423465064000},"page":"39-45","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extrakardiale Manifestation der Lipoprotein(a)-Erh\u00f6hung \u2013 Geh\u00e4uftes Auftreten von peripherer arterieller Verschlusskrankheit und Stenosen der Arteria carotis"],"prefix":"10.1007","volume":"10","author":[{"given":"Frank","family":"van Buuren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Alexia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Kottmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Horstkotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus Peter","family":"Mellwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"69_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2009.12.036","volume":"211","author":"PR Kamstrup","year":"2010","unstructured":"Kamstrup PR (2010) Lipoprotein(a) and ischemic heart disease\u2013a causal association? A review. Atherosclerosis 211:15\u201323","journal-title":"Atherosclerosis"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL et al, Emerging Risk Factors Collaboration (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412\u2013423","journal-title":"JAMA"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","volume":"19","author":"PR Kamstrup","year":"2013","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG (2013) Extreme lipoprotein (a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 19:1146\u20131156","journal-title":"J Am Coll Cardiol"},{"key":"69_CR4","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokg\u00f6zoglu L, Tybj\u00e6rg-Hansen A, European Atherosclerosis Society Consensus Panel (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:2844\u20132853","journal-title":"Eur Heart J"},{"key":"69_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCGENETICS.110.958371","volume":"4","author":"JC Hopewell","year":"2011","unstructured":"Hopewell JC, Clarke R, Parish S, Armitage J, Lathrop M, Hager J, Collins R, Heart Protection Study Collaborative Group (2011) Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study. Circ Cardiovasc Genet 4:68\u201373","journal-title":"Circ Cardiovasc Genet"},{"key":"69_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2014.05.944","volume":"235","author":"MV Ezhov","year":"2014","unstructured":"Ezhov MV, Safarova MS, Afanasieva OI, Kukharchuk VV, Pokrovsky SN (2014) Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting. Atherosclerosis 235:477\u2013482","journal-title":"Atherosclerosis"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvu107","volume":"103","author":"A Laschkolnig","year":"2014","unstructured":"Laschkolnig A, Kollerits B, Lamina C, Meisinger C, Rantner B, Stadler M, Peters A, Koenig W, St\u00f6ckl A, D\u00e4hnhardt D, B\u00f6ger CA, Kr\u00e4mer BK, Fraedrich G, Strauch K, Kronenberg F (2014) Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts. Cardiovasc Res 103:28\u201336","journal-title":"Cardiovasc Res"},{"key":"69_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2362.2007.01747.x","volume":"37","author":"T Maca","year":"2007","unstructured":"Maca T, Mlekusch W, Doweik L, Budinsky AC, Bischof M, Minar E, Schillinger M (2007) Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease. Eur J Clin Invest 37:180\u2013186","journal-title":"Eur J Clin Invest"},{"key":"69_CR9","first-page":"357","volume":"14","author":"M Prior","year":"1995","unstructured":"Prior M, Arosio E, Ferrari M, Lucchese L, Guidi GC, Bosello O (1995) Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease. Int Angiol 14:357\u2013363","journal-title":"Int Angiol"},{"key":"69_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02002128","volume":"7","author":"MD Widmann","year":"1993","unstructured":"Widmann MD, Sumpio BE (1993) Lipoprotein (a): a risk factor for peripheral vascular disease. Ann Vasc Surg 7:446\u2013451","journal-title":"Ann Vasc Surg"},{"key":"69_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2796.1992.tb00596.x","volume":"232","author":"J Tyrrell","year":"1992","unstructured":"Tyrrell J, Cooke T, Reilly M, Colgan M, Moore D, Shanik DG, Bergin C, Feely J (1992) Lipoprotein [Lp(a)] and peripheral vascular disease. J Intern Med 232:349\u2013352","journal-title":"J Intern Med"},{"key":"69_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00508-010-1318-0","volume":"122","author":"J Boras","year":"2010","unstructured":"Boras J, Ljubic S, Car N, Metelko Z, Petrovecki M, Lovrencic MV, Reiner Z (2010) Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: a four-year follow-up. Wien Klin Wochenschr 122:159\u2013164","journal-title":"Wien Klin Wochenschr"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diacare.22.1.93","volume":"22","author":"F Wollesen","year":"1999","unstructured":"Wollesen F, Dahl\u00e9n G, Berglund L, Berne C (1999) Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care 22:93\u201398","journal-title":"Diabetes Care"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2003.030031","volume":"50","author":"N Rifai","year":"2004","unstructured":"Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJ, Stampfer MJ, Marcovina SM (2004) Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the Physicians\u2019 Health Study. Clin Chem 50:1364\u20131371","journal-title":"Clin Chem"},{"key":"69_CR15","unstructured":"Sommer JA (2015) Die Bedeutung der Lipoprotein (a) Erh\u00f6hung f\u00fcr die Entstehung der Arteriosklerose. Dissertation Universit\u00e4t Bochum. Eingereicht 2015"},{"key":"69_CR16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9149(02)02192-6","volume":"89","author":"V Solfrizzi","year":"2002","unstructured":"Solfrizzi V, Panza F, Colacicco AM, Capurso C, D\u2019Introno A, Torres F, Baldassarre G, Capurso A (2002) Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =\u00a065 years of age (The Italian Longitudinal Study on Aging). Am J Cardiol 89:825\u2013829","journal-title":"Am J Cardiol"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2011.05.039","volume":"219","author":"P Song","year":"2011","unstructured":"Song P, Seok JM, Kim WS, Lee YT, Kim DK, Kim GM (2011) Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft. Atherosclerosis 219:285\u2013290","journal-title":"Atherosclerosis"},{"key":"69_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.arteri.2014.01.001","volume":"26","author":"AM Bea","year":"2014","unstructured":"Bea AM, Mateo-Gallego R, Jarauta E, Villa-Pobo R, Calmarza P, Lamiquiz-Moneo I, Cenarro A, Civeira F (2014) Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia. Clin Investig Arterioscler 26:176\u2013183","journal-title":"Clin Investig Arterioscler"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5812\/nephropathol.9092","volume":"2","author":"A Ghorbani","year":"2013","unstructured":"Ghorbani A, Rafieian-Kopaei M, Nasri H (2013) Lipoprotein (a): more than a bystander in the etiology of hypertension? A study on essential hypertensive patients not yet on treatment. J Nephropathol 2:67\u201370","journal-title":"J Nephropathol"},{"key":"69_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1744-9987.2006.00441.x","volume":"10","author":"KP Mellwig","year":"2006","unstructured":"Mellwig KP, van Buuren F, Schmidt HK, Wielepp P, Burchert W, Horstkotte D (2006) Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment. Ther Apher Dial 10:510\u2013517","journal-title":"Ther Apher Dial"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/ejvs.2000.1100","volume":"20","author":"A Dionyssiou-Asteriou","year":"2000","unstructured":"Dionyssiou-Asteriou A, Papastamatiou M, Vatalas I, Bastounis E (2000) Serum Lp(a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities. Eur J Vasc Endovasc Surg 20:57\u201360","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","volume":"285","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481\u20132485","journal-title":"JAMA"},{"key":"69_CR23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.amjcard.2010.01.370","volume":"105","author":"S Volpato","year":"2010","unstructured":"Volpato S, Vigna GB, McDermott MM, Cavalieri M, Maraldi C, Lauretani F, Bandinelli S, Zuliani G, Guralnik JM, Fellin R, Ferrucci L (2010) Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol 105:1825\u20131830","journal-title":"Am J Cardiol"},{"key":"69_CR24","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/CIRCULATIONAHA.105.608679","volume":"113","author":"V Aboyans","year":"2006","unstructured":"Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A (2006) Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113:2623\u20132629","journal-title":"Circulation"},{"key":"69_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1567-5688(09)71817-3","volume":"10","author":"S Tselmin","year":"2009","unstructured":"Tselmin S, Julius U, M\u00fcller G, Fischer S, Bornstein SR (2009) Cardiovascular events in patients with increased lipoprotein(a) \u2013 retrospective data analysis in an outpatient department of lipid disorders. Atherosclerosis Suppl 10:79\u201384","journal-title":"Atherosclerosis Suppl"},{"key":"69_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/aor.12135","volume":"38","author":"A Rosada","year":"2014","unstructured":"Rosada A, Kassner U, Vogt A, Wilhauck M, Parhofer K, Steinhagen-Thiessen E (2014) Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events? Artificial Organs 38:135\u2013141","journal-title":"Artificial Organs"},{"key":"69_CR27","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.113.002432","volume":"128","author":"J Leebmann","year":"2013","unstructured":"Leebmann J, Roeseler E, Julius U et al, Pro(a) LiFe Study Group (2013) Lipoprotein apheresis in patients with maximally tolerated lipid lowering therapy, lipoprotein(a)- hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation 128:2567\u20132576","journal-title":"Circulation"},{"key":"69_CR28","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301:2331\u20132339","journal-title":"JAMA"},{"key":"69_CR29","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","volume":"32","author":"D Gurdasani","year":"2012","unstructured":"Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN, Wainwright NW, Pomilla C, Wareham NJ, Khaw KT, Boekholdt SM, Sandhu MS (2012) Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 32:3058\u20133065","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"69_CR30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10753-013-9785-x","volume":"37","author":"SY Li","year":"2014","unstructured":"Li SY, Gao Y, Ma WN, Wang HC, Zhou G, Guo WC, Liu YH (2014) The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population. Inflammation 37:686\u2013693","journal-title":"Inflammation"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-015-0069-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0069-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:15:55Z","timestamp":1553642155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-015-0069-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":30,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s11789-015-0069-x","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]}}}